Tumor detection with some 99mTc-labeled S-containing amino acids

Area of Science:

• Nuclear medicine
• Radiochemistry
• Oncology

Background:

• Diagnostic imaging is crucial for effective tumor detection and management.
• Development of novel radiotracers can improve the specificity and sensitivity of tumor imaging.
• Amino acid derivatives are explored as potential tumor-targeting agents due to their altered metabolism in cancer cells.

Purpose of the Study:

• To synthesize and evaluate three 99mTc-labeled amino acid derivatives for potential use in nuclear medical tumor imaging.
• To compare the efficacy of 99mTc-L-cysteine, 99mTc-DL-homocysteine, and 99mTc-S-carbamyl-L-cysteine in gamma camera imaging and biodistribution studies.
• To identify the most promising radiotracer for preclinical evaluation in tumor-bearing models.

Main Methods:

• Synthesis of 99mTc-labeled L-cysteine, DL-homocysteine, and S-carbamyl-L-cysteine.
• In vitro assessment of radiolabeling efficiency and stability.
• In vivo biodistribution studies in mice bearing Ehrlich solid tumors.
• Gamma camera imaging to evaluate tumor uptake and visualization.

Main Results:

• All three compounds were successfully labeled with 99mTc.
• Biodistribution studies revealed differential uptake patterns in tumor-bearing mice.
• 99mTc-DL-homocysteine demonstrated favorable characteristics for tumor imaging, including significant tumor accumulation and retention.
• Gamma camera imaging confirmed the potential of 99mTc-DL-homocysteine to visualize Ehrlich solid tumors.

Conclusions:

• 99mTc-DL-homocysteine is a promising candidate for nuclear medical imaging of tumors.
• Further investigation is warranted to explore its clinical utility in oncology.
• The study highlights the potential of modified amino acids as radiotracers for cancer diagnosis.